Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment

Substance Use and Misuse

Volumn 43, Issue 5, 2008, Pages 612-632

  Astals, Mònica ^a,b   Domingo Salvany, Antònia ^c   Buenaventura, Claudio Castillo ^a   Tato, Jordi ^d   Vazquez, José Ma ^e   Martín Santos, Rocío ^a   Torrens, Marta ^a  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^d Centre d'Atenció I Seguiment Creu Roja   (Spain)

^e Centre d'Atenció I Seguiment Sants   (Spain)

Author keywords

Dual diagnosis; Heroin dependence; Methadone; Psychiatric comorbidity; Quality of life

Indexed keywords

METHADONE;

ADULT; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOOD DISORDER; PERSONALITY DISORDER; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; SUBSTANCE ABUSE;

EID: 41949102732     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.1080/10826080701204813     Document Type: Article

References (41)

1. Aharonovich, E., Liu, X., Nunes, E., Hasin, D. S. (2002). Suicide attempts in substance abusers: effects of major depression in relation to substance use disorders. American Journal of Psychiatry 159:1600-1602.
2. Alonso, J., Ferrer, M., Gandek, B., Ware, J. E. Jr., Aaronson, N. K., Mosconi, P., et al. (2004). Health related quality of life associated with chronic conditions in eight countries: Results from the international quality of life assessment (IQOLA) project. Quality of Life Research 13:283-298.
3. Bizzarri, J., Rucci, P., Vallotta, A., Girelli, M., Scandolari, A., Zerbetto, E., et al. (2005). Dual diagnosis and quality of life in patients in treatment for opioid dependence. Substance Use Misuse 40:1765-1776.
4. Brooner, R. K., Greenfield, L., Schmidt, C. W., Bigelow, G. E. (1993). Antisocial personality disorder and HIV infection among intravenous drug abusers. American Journal of Psychiatry 150:53-58.
5. Brooner, R. K., King, V. L., Kidorf, M., Schmidt, C. W., Bigelow, G. (1997). Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Archives of General Psychiatry 54:71-80.
6. Cacciola, J., Alterman, A., Rutherford, M., Mckay, J., Mulvaney, F. (2001). The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug and Alcohol Dependence 61:271-280.
7. Calsyn, D. A., Saxon, A. J., Bush, K. R., Howell, D. N., Baer, J. S., Sloan, K. L., et al. (2004). The Addiction Severity Index medical and psychiatric composite scores measure similar domains as the SF-36 in substance-dependent veterans: concurrent and discriminant validity. Drug and Alcohol Dependence 76:165-171.
8. Chen, C. C., Tsai, S. Y., Su, L. W., Yang, T. W., Tsai, C. J., Hwu, H. G. (1999). Psychiatric comorbidity among male heroin addicts: differences between hospital and incarcerated subjects in Taiwan. Addiction 94:825-32.
9. Curran, G. M., Sullivan, G., Williams, K., Han, X., Collins, K., Keys, J., et al. (2003). Emergency department use of persons with comorbid psychiatric and substance abuse disorders. Annals of Emergency Medicine 41:659-667.
10. Direcció General de Drogodependències i SIDA. (2002). Generalitat de Catalunya. Departament de Sanitat i Seguretat Social. Sistema d'Informació sobre Drogodependències a Catalunya. Informe anual 2001. Barcelona.
11. Eland-Goossensen M. A., Van der Goor L. A. M., Garretsen, H. F. L., Shudel, W. J. (1997). Opiate addicts in and outside treatment compared on psychopathology. European Addiction Research 3:164-172.
12. ESEMeD/ MHEDEA 2000 investigators. (2204). Disability and quality of life impact of mental disorders in Europe: Results from the European study of the epidemiology of mental disorders (ESEMeD) project. Acta Psychiatrica Scandinavica 109 (Suppl 420):38-46.
13. Fassino, S., Daga, G. A., Delsedime, N., Rogna, L., Boggio, S. (2004). Quality of life and personality disorders in heroin abusers. Drug and Alcohol Dependence 76:73-80.
14. First, M. B., Spitzer, R. L., Gibbon, M., Williams, J. B. W. (1997).Structured clinical interview for DSM-IV Axis I Disorders-Clinician Version (SCID-IV). Washington, DC: American Psychiatric Press, Inc., 1997.
15. Giacomuzzi, S. M., Riemer, M., Ertl, M., Rossler, H., Hinterhuber, H., Kurz, M. (2003). Buprenorphine versus methadone maintenance treatment in an ambulant setting: A health-related quality of life assessment. Addiction 98:693-702.
16. Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., (2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders. Archives of General Psychiatry 61:807-816.
17. Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Ruan, W. J. (2005). Co-occurrence of DSM-IV personality disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Comprehensive Psychiatry 46:1-5.
18. Guyatt, G. H., Feeny, D. H., Patrick, D. L. (1993). Measuring health-related quality of life. A conceptual model of patients outcomes. Annals of Internal Medicine 118:622-629.
19. Hasin, D. S., Samet, S., Nunes, E., Meydan, J., Matseoane, K., Waxman, R. (2006). Diagnosis of comorbid disorders in substance users: Psychiatric Research Interview for Substance and Mental Disorders (PRISM-IV). American Journal of Psychiatry 163:689-696.
20. Heiligenstein, J. H., Ware, J. E. Jr., Beusterien, K. M., Roback, P. J., Andrejasich, C., Tollefson, G. D. (1995). Acute effects of fluoxetine versus placebo on functional health and well-being in late-life depression. International Psychogeriatrics 7:125-137.
21. Hernandez-Avila, C. A., Rounsaville, B. J., Kranzler, H. R. (2004). Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug and Alcohol Dependence 74:265-272.
22. Janca, A., Ustun, T. B., Sartorius, N. (1994). New versions of World Health Organization instruments for the assessment of mental disorders. Acta Psychiatrica Scandinavica 90:73-83.
23. Kidorf, M., Disney, E. R., King, V.L., Neufeld, K., Beilenson, P.L., Brooner, R. K. (2004). Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. Drug and Alcohol Dependence 74:115-122.
24. King, V. L., Kidorf, M. S., Stoller, K. B., Brooner, R. K. (2000). Influence of psychiatric comorbidity on HIV risk behaviors: changes during drug abuse treatment. Journal of Addictive Diseases 19:65-83.
25. Krausz, M., Verthein, U., Degkwitz, P. (1999). Psychiatric comorbidity in opiate addicts. European Addiction Research 5:55-62.
26. Mason, B., Kocsis, J., Melia, D., Khuri, E. T., Sweeney, J., Wells, A., et al. (1998). Psychiatric comorbidity in methadone maintained patients. Journal of Addictive Diseases 17:75-89.
27. McLellan, A. T., Luborsky, L., Woody, G. E., O'Brien, C. P. (1980). An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. Journal of Nervous and Mental Disease 168:26-33.
28. Millson, P. E., Challacombe, L., Villeneuve, P. J., Fischer, B., Strike, C. J., Myers, T., et al. (2004). Self-perceived health among Canadian opiate users: A comparison to the general population and to other chronic disease populations. Canadian Journal of Public Health 95 (Suppl 2, Health Module):99-103.
29. Puigdollers, E., Cots, F., Brugal, M.T., Torralba, L., Domingo-Salvany, A., Costas, F. (2003). Methadone maintenance programs with supplementary services: A cost-effectiveness study. Gaceta Sanitaria 17:123-130.
30. Puigdollers, E., Domingo-Salvany, A., Brugal, M. T., Torrens, M., Alvaros, J., Castillo, C., et al. (2004). Characteristics of heroin addicts entering methadone maintenance: Quality of life and gender. Substance Use and Misuse 39:1353-1368.
31. Rodriguez Llera, M. C., Domingo-Salvany, A., Brugal, M. T. (2006). Psychiatric comorbidity in young heroin users. Drug and Alcohol Dependence 84:48-55.
32. Ryan, C.F., White, J. (1996). Health status at entry to methadone maintenance treatment using the SF-36 health survey questionnaire. Addiction 91:39-45.
33. Spitzer, R.L., Kroenke, K., Linzer, M., Hahn, S.R., Williams, J.B., deGruy, F.V., 3rd., Broody, D., Davies, M. (1995). Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 Study. Journal of the American Medical Association 274:1511-1517.
34. Strain, E. C., Brooner, R. K., Bigelow, G. E. (1991). Clustering of multiple substance use and psychiatric diagnoses in opiate addicts. Drug and Alcohol Dependence 27:127-134.
35. Torrens, M., Domingo-Salvany, A., Alonso, J., Castillo, C., San, L. (1999). Methadone and quality of life. Lancet 353:1101.
36. Torrens, M., Fonseca, F., Mateu, G., Farré, M. (2005). Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis. Drug and Alcohol Dependence 78:1-22.
37. Torrens, M., San, L., Martinez, A., Castillo, C., Domingo-Salvany, A., Alonso, J. (1997). Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment. Addiction 92:707-716.
38. Torrens, M., Serrano, D., Astals, M., Pérez-Domínguez, G., Martín-Santos, R. (2004). Diagnosing psychiatric comorbidity in substance abusers. Validity of the Spanish versions of Psychiatric Research Interview for Substance and Mental Disorders (PRISM-IV) and the Structured Clinical Interview for DSM-IV (SCID-IV). American Journal of Psychiatry 161:1231-1237.
39. Ware, J. E., Gandek, B. (1994). The SF-36 Health Survey: development and use in mental health research and the IQOLA Project. International Journal of Mental Health 23:49-73.
40. Ware, J. E., Kosinski, M., Turner-Bowker, D. M., Gandek, B. (2002). How to score version 2 of the SF-12 Health Survey. Quality Metrics: Lincoln, RI.
41. World Health Organization (WHO). (1998). Composite International Diagnostic Interview (CIDI). Core, Version 2.1.